p38 MAPK Endogenous Inhibition Improves Neurological Deficits in Global Cerebral Ischemia/Reperfusion Mice

Figure 1

Basic depiction of the experimental design. Global cerebral ischemia/reperfusion treatment at the age of about eight-week-old male mice. In this study, three experimental groups were analyzed: sham group, WT & I/R group, and p38^KI/+ & I/R group. TTC staining, western blot analysis, TUNEL staining, and neurological score were performed and analyzed.